Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38,539,454
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
7,295,353
-
Shares change
-
+727,849
-
Total reported value, excl. options
-
$40,942,337
-
Value change
-
+$3,826,530
-
Put/Call ratio
-
50%
-
Number of buys
-
36
-
Number of sells
-
-34
-
Price
-
$5.61
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q2 2022
95 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q2 2022.
Co-Diagnostics, Inc. - Common Stock (CODX) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,295,353 shares
of 38,539,454 outstanding shares and own 19% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2,023,232 shares), RENAISSANCE TECHNOLOGIES LLC (683,500 shares), MORGAN STANLEY (505,862 shares), BlackRock Inc. (501,642 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (391,900 shares), GEODE CAPITAL MANAGEMENT, LLC (301,202 shares), ACADIAN ASSET MANAGEMENT LLC (238,095 shares), Bank of New York Mellon Corp (223,349 shares), GLOBEFLEX CAPITAL L P (220,479 shares), and MILLENNIUM MANAGEMENT LLC (164,437 shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.